Novartis is committed to supporting grant requests for projects which improve patient care, either directly or through supporting the NHS, and also those which provide ongoing meeting-led education for medical professionals and patients.
As a general guidance, Novartis will also consider projects which have a major focus on ensuring good clinical practice, including requests for medical equipment.
In order to be considered all grants will need to meet Novartis standards of good ethical practice. Grant requests will also need to meet all UK requirements under the Association of British Pharmaceutical Industry (ABPI) PMCPA Code of Practice and the Medicines and Healthcare Products Regulatory Agency (MHRA) regulations. Novartis standards on grant provision may be more stringent than that of the external regulators.
Where support might be given
Unfortunately, Novartis is unable to meet all of the requests it receives. We will prioritise those requests which are aligned to our therapy areas and focus on supporting both scientific and charitable organisations which directly support patients, improve healthcare and enable ongoing education.
Educational grants will be considered which support the organisation of meetings where the content of the programme is wholly controlled by an independent organisation and Novartis has no input or influence over the content. If a grant is awarded, this support must be acknowledged on any documentation advertising the event. A key principle of Novartis grant policy is that Novartis no longer gives grants to, or through, individuals, and therefore we are unable to support requests from individuals for their personal ongoing education. This means that we cannot provide travel grants for individuals. For example, we cannot award a grant for transport, accommodation or registration to attend an educational meeting. This does not affect Novartis hosted groups invited to congresses.
Requests should be submitted a minimum of three months prior to the activity or event. Each request will be evaluated on its merits and the value it brings to patient care and benefit to the NHS.
Please read carefully the eligibility criteria (see below) and the information required before you complete your application form.
In order to apply for a Novartis grant, download the relevant form (see below) and submit it to [email protected]. The forms are PDFs and use Adobe Acrobat software. You can download this free from Adobe.
Please note that is important to fill out all the sections on the form with the information required as failure to do so could result in either a rejection or a request for additional information which will delay your application.
If you have any supporting documentation you consider relevant to the application you can attach this to your email.
Applications may also be completed and posted to UK GRANTS at Novartis Pharmaceuticals UK Ltd, Frimley Business Park, Camberley, Surrey GU16 7SR. Please note due to legibility concerns we advise that forms should be completed electronically.
The personal information you submit in your application will be used by Novartis only for the purposes of processing the grant application, and any associated disclosure. Any and all uses will comply with all applicable laws.
All requests are monitored for reporting adverse events. You agree to be contacted should your completed application form contain information relevant to our adverse event reporting commitments.
All requests are reviewed by an independent Grant Review Panel composed of compliance, medical and legal to ensure no commercial considerations influence the grant request and ensure fairness and consistency of approach. Results will be communicated after the Grant Review Panel has met. Grants can only be paid to reputable healthcare organisations and checks on organisations to confirm this will be made. The ABPI PMCPA Code of Practice requires all pharmaceutical companies to report every grant given to a healthcare organisation on an annual basis. In order to track spend for reporting purposes, Novartis can only pay healthcare organisations directly.